Metastatic Thyroid Gland Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08912 | Dabrafenib | 1 | Active Not Recruiting | 1 |
DB01259 | Lapatinib | 1 | Active Not Recruiting | 1 |
DB15994 | Methane | 1 | Active Not Recruiting | 1 |
DB00062 | Albumin human | 2 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB11967 | Binimetinib | 2 | Recruiting | 1 |
DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
DB11718 | Encorafenib | 2 | Recruiting | 1 |
DB09293 | Iodide I-131 | 2 | Active Not Recruiting | 1 |
DB09078 | Lenvatinib | 2 | Recruiting | 1 |
DB09078 | Lenvatinib | 2 | Withdrawn | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
DB11689 | Selumetinib | 2 | Active Not Recruiting | 1 |
DB08911 | Trametinib | 2 | Active Not Recruiting | 1 |
DB08881 | Vemurafenib | 2 | Active Not Recruiting | 1 |